Uveal Melanoma - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 01-Nov-2017
No. of pages: 70
Price : Single User: US $ 5750  US $ 4600 Corporate User: US $ 17250  US $ 10350
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Uveal Melanoma - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Uveal Melanoma for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Uveal Melanoma . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Uveal Melanoma for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Uveal Melanoma market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Uveal Melanoma , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Uveal Melanoma for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Uveal Melanoma 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Uveal Melanoma market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Uveal Melanoma covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Uveal Melanoma .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Uveal Melanoma .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Uveal Melanoma market trends.

  • Thorough market distribution based on market share for Uveal Melanoma .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Uveal Melanoma market.

  • To understand the future market competition in the Uveal Melanoma market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Uveal Melanoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Uveal Melanoma - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Uveal Melanoma Market Overview at a Glance
2.1. Total Market Share Distribution of Uveal Melanoma for 7 MM in 2016
2.2. Total Market Share Distribution of Uveal Melanoma for 7 MM in 2025

3. Uveal Melanoma
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Uveal Melanoma in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Uveal Melanoma in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Uveal Melanoma in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Uveal Melanoma in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Uveal Melanoma in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Uveal Melanoma in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Uveal Melanoma
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Uveal Melanoma Market (2016 & 2025)

9. Uveal Melanoma : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Uveal Melanoma in United States (2015-2025)
Table 2: Diagnosed Cases Uveal Melanoma in Germany (2015-2025)
Table 3: Diagnosed Cases Uveal Melanoma in France (2015-2025)
Table 4: Diagnosed Cases Uveal Melanoma in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Uveal Melanoma in Spain (2015-2025)
Table 6: Diagnosed Cases Uveal Melanoma in Italy (2015-2025)
Table 7: Diagnosed Cases Uveal Melanoma in Japan (2015-2025)
Table 8: List of Marketed Drugs for Uveal Melanoma
Table 9: List of Pipeline Phase III Drugs for Uveal Melanoma
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 17: Germany Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 18: France Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 20: Spain Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 21: Italy Market Size of Uveal Melanoma in USD, Million (2015-2025)
Table 22: Japan Market Size of Uveal Melanoma in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Uveal Melanoma in United States (2015-2025)
Figure 2: Diagnosed Cases Uveal Melanoma in Germany (2015-2025)
Figure 3: Diagnosed Cases Uveal Melanoma in France (2015-2025)
Figure 4: Diagnosed Cases Uveal Melanoma in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Uveal Melanoma in Spain (2015-2025)
Figure 6: Diagnosed Cases Uveal Melanoma in Italy (2015-2025)
Figure 7: Diagnosed Cases Uveal Melanoma in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Uveal Melanoma
Figure 9: List of Pipeline Phase III Drugs for Uveal Melanoma
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 17: Germany Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 18: France Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 20: Spain Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 21: Italy Market Size of Uveal Melanoma in USD, Million (2015-2025)
Figure 22: Japan Market Size of Uveal Melanoma in USD, Million (2015-2025)
  • China Artificial Tears Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 08-Dec-2017        Price: US 4480 Onwards        Pages: 124
    This report studies the Artificial Tears market, Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. Scope of the Report: This report focuses on the Artificial Tears in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Seg......
  • Global Eye Drops & Lubricants Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Eye Drops & Lubricants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Eye Drops & Lubricants for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • United States Ophthalmic Therapeutic Drugs Market Report 2017
    Published: 06-Dec-2017        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gr......
  • China Conjunctivitis Market Research Report 2017
    Published: 06-Dec-2017        Price: US 3400 Onwards        Pages: 112
    The global Conjunctivitis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Conjunctivitis development status and future trend in China, focuses on top players in China, also splits Conjunctivitis b......
  • United States Latanoprost Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 05-Dec-2017        Price: US 4480 Onwards        Pages: 119
    "Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressur......
  • Global Ophthalmic Therapeutic Drugs Sales Market Report 2017
    Published: 01-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast) , covering - United States - China ......
  • Macular Edema - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 42
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H2 2017, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently ......
  • Retinal Vein Occlusion - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 90
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Pipeline Review, H2 2017, provides an overview of the Retinal Vein Occlusion (Ophthalmology) pipeline landscape. Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vis......
  • Global Conjunctivitis Market Professional Survey Report 2017
    Published: 27-Nov-2017        Price: US 3500 Onwards        Pages: 110
    This report studies Conjunctivitis in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Novartis - Santen Pharmaceutical - Bausch + Lomb - Allergan - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs